KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to -$207.1 million.

  • Idexx Laboratories' Cash from Investing Activities fell 63.95% to -$44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$148.0 million, marking a year-over-year increase of 25.15%. This contributed to the annual value of -$207.1 million for FY2024, which is 65.31% down from last year.
  • Idexx Laboratories' Cash from Investing Activities amounted to -$207.1 million in FY2024, which was down 65.31% from -$125.3 million recorded in FY2023.
  • Idexx Laboratories' Cash from Investing Activities' 5-year high stood at -$109.4 million during FY2020, with a 5-year trough of -$293.0 million in FY2021.
  • Over the past 3 years, Idexx Laboratories' median Cash from Investing Activities value was -$195.3 million (recorded in 2022), while the average stood at -$175.9 million.
  • In the last 5 years, Idexx Laboratories' Cash from Investing Activities spiked by 46.78% in 2020 and then plummeted by 167.85% in 2021.
  • Over the past 5 years, Idexx Laboratories' Cash from Investing Activities (Yearly) stood at -$109.4 million in 2020, then slumped by 167.85% to -$293.0 million in 2021, then soared by 33.32% to -$195.3 million in 2022, then skyrocketed by 35.88% to -$125.3 million in 2023, then plummeted by 65.31% to -$207.1 million in 2024.